Drug intelligence / Profile preview

Danggui Yangxue Wan

Development stage: Unknown
Lead developer: Zhongshan Shaxi Chinese Medicine Factory
Modality: Small Molecules
Administration: Oral

Overview

Danggui Yangxue Wan is a Traditional Chinese Medicine (TCM) product developed and manufactured by Zhongshan Shaxi Chinese Medicine Factory. Formulated as a pill, it is primarily indicated for nourishing blood and regulating menstruation. The preparation is used to treat symptoms associated with blood deficiency, including anemia, sallow complexion, dizziness, palpitations, and irregular or painful menstruation. Its composition typically includes *Angelica sinensis* (Danggui) as the principal herb, supported by *Astragalus membranaceus* and other tonifying herbs. In TCM theory, it works by tonifying Qi and blood to restore physiological balance and improve microcirculation.

Brand names: Danggui Yangxue Wan
Other names: Angelica Blood-Nourishing Pill

Beyond the preview

Go deeper on Danggui Yangxue Wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Danggui Yangxue Wan.

Explore the full profile